$ARNA Headlines S&P 500 back for another crack
Post# of 102250
Posted On: 12/27/2014 10:03:10 AM
$ARNA Headlines
S&P 500 back for another crack at major support 11:21 a.m. Jan. 31, 2014 - Michael Ashbaugh
Arena shares surge as marketer doubles sales force for diet drug 11:41 a.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 12:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 1:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 1:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 6:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 9:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 9:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 6:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 6:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 7:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 12:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 11:07 a.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 7:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 7:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 12:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 1:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 3:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 2:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 9:32 a.m. July 30, 2012 - Val Brickates Kennedy
Is Vivus Headed Towards An Unfortunate Ending? 8:27 a.m. Today - Seeking Alpha
4 Potential Blockbuster Drugs The FDA Just Approved 11:35 a.m. Dec. 26, 2014 - Investors Business Daily
First Week Of March 2015 Options Trading For Arena Pharmaceuticals 11:32 a.m. Dec. 26, 2014 - TheStreet.com
Arena Pharmaceuticals (ARNA): Today's Weak On High Volume Stock 10:22 a.m. Dec. 26, 2014 - TheStreet.com
Novo Nordisk's Saxenda Gets FDA Nod, Launch in 1H15 - Analyst Blog 4:20 p.m. Dec. 24, 2014 - Zacks.com
Novo Nordisk Enters Anti-Obesity Space With New FDA Approval 7:46 a.m. Dec. 24, 2014 - Seeking Alpha
FDA clears Novo weight management drug 4:05 p.m. Dec. 23, 2014 - Seeking Alpha
Contrave Prescriptions Still Rising In A Down Week 3:47 p.m. Dec. 22, 2014 - Seeking Alpha
Orexigen - Contrave Script Numbers Remain Impressive 3:31 p.m. Dec. 22, 2014 - Seeking Alpha
Belviq Scripts Dip - Lack Of T.V. Ads Will Impact Next Numbers 3:27 p.m. Dec. 22, 2014 - Seeking Alpha
Orexigen Retreats After Positive News In Europe: 3 Things To Watch For 3:18 p.m. Dec. 22, 2014 - Seeking Alpha
Arena And Vivus Investors Need To Grasp Implications Of Orexigen 2:22 p.m. Dec. 19, 2014 - Seeking Alpha
Orexigen Therapeutics Gains On Diet Pill Nod From European Committee 1:09 p.m. Dec. 19, 2014 - benzinga.com
Orexigen's 'Goldilocks' Weight-Loss Pill is Just Right for European Regulators 8:25 a.m. Dec. 19, 2014 - TheStreet.com
Low-Cost Contrave Fuels Anti-Obesity Drugs Recovery From Thanksgiving 1:50 a.m. Dec. 16, 2014 - Seeking Alpha
Why Should Investors Expect Physicians To Treat Obesity With Pharmacotherapy? 10:30 a.m. Dec. 15, 2014 - Seeking Alpha
Zafgen starts clinical trial in severe obesity and type 2 diabetes 7:43 a.m. Dec. 15, 2014 - Seeking Alpha
Contrave Sales Continue To Impress 4:26 p.m. Dec. 12, 2014 - Seeking Alpha
Arena: Belviq Sales See Pleasant Rebound 4:05 p.m. Dec. 12, 2014 - Seeking Alpha
Arena Pharmaceuticals (ARNA) Weak On High Volume Today 10:01 a.m. Dec. 12, 2014 - TheStreet.com
Arena Pharmaceuticals Issued Composition of Matter Patent by United States Patent and Trademark Office for Ralinepag and Related Compounds 8:00 a.m. Nov. 25, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 8:00 a.m. Nov. 24, 2014 - PR Newswire - PRF
Technical Updates on Biotech Stocks - ImmunoGen, Lexicon Pharma, ZIOPHARM Oncology, Arena Pharma, and Regulus Therapeutics 8:40 a.m. Nov. 19, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Stifel 2014 Healthcare Conference 8:00 a.m. Nov. 13, 2014 - PR Newswire - PRF
Lorcaserin HCl Data to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases 8:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference 8:00 a.m. Nov. 5, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2014 Financial Results 6:45 a.m. Nov. 3, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Report Results of an Investigational Phase 2 Trial of Lorcaserin HCl as an Aid for Smoking Cessation 6:30 a.m. Nov. 3, 2014 - PR Newswire - PRF
Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting 7:37 a.m. Oct. 31, 2014 - PR Newswire - PRF
Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting 7:00 a.m. Oct. 31, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Report Results of an Investigational Pilot Study of Coadministration of Lorcaserin HCl and Phentermine HCl 5:20 p.m. Oct. 28, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Announces Third Quarter 2014 Conference Call and Webcast on Monday, November 3 7:00 a.m. Oct. 27, 2014 - PR Newswire - PRF
Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 8:30 a.m. Oct. 17, 2014 - PR Newswire - PRF
Global Anti-Obesity Drugs Market 4:07 p.m. Oct. 16, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Announce Publication of Pooled Phase 3 Clinical Trial Analysis of BELVIQ® (lorcaserin HCl) CIV in Postgraduate Medicine 10:36 a.m. Oct. 10, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 7:00 a.m. Sept. 22, 2014 - PR Newswire - PRF
Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 7:15 a.m. Sept. 19, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 7:40 a.m. Sept. 12, 2014 - PR Newswire - PRF
Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 7:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Post-Earnings Review and Highlights - Arena Pharma 8:30 a.m. Aug. 11, 2014 - PR Newswire - PRF
S&P 500 back for another crack at major support 11:21 a.m. Jan. 31, 2014 - Michael Ashbaugh
Arena shares surge as marketer doubles sales force for diet drug 11:41 a.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 12:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 1:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 1:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 6:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 9:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 9:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 6:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 6:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 7:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 12:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 11:07 a.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 7:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 7:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 12:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 1:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 3:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 2:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 9:32 a.m. July 30, 2012 - Val Brickates Kennedy
Is Vivus Headed Towards An Unfortunate Ending? 8:27 a.m. Today - Seeking Alpha
4 Potential Blockbuster Drugs The FDA Just Approved 11:35 a.m. Dec. 26, 2014 - Investors Business Daily
First Week Of March 2015 Options Trading For Arena Pharmaceuticals 11:32 a.m. Dec. 26, 2014 - TheStreet.com
Arena Pharmaceuticals (ARNA): Today's Weak On High Volume Stock 10:22 a.m. Dec. 26, 2014 - TheStreet.com
Novo Nordisk's Saxenda Gets FDA Nod, Launch in 1H15 - Analyst Blog 4:20 p.m. Dec. 24, 2014 - Zacks.com
Novo Nordisk Enters Anti-Obesity Space With New FDA Approval 7:46 a.m. Dec. 24, 2014 - Seeking Alpha
FDA clears Novo weight management drug 4:05 p.m. Dec. 23, 2014 - Seeking Alpha
Contrave Prescriptions Still Rising In A Down Week 3:47 p.m. Dec. 22, 2014 - Seeking Alpha
Orexigen - Contrave Script Numbers Remain Impressive 3:31 p.m. Dec. 22, 2014 - Seeking Alpha
Belviq Scripts Dip - Lack Of T.V. Ads Will Impact Next Numbers 3:27 p.m. Dec. 22, 2014 - Seeking Alpha
Orexigen Retreats After Positive News In Europe: 3 Things To Watch For 3:18 p.m. Dec. 22, 2014 - Seeking Alpha
Arena And Vivus Investors Need To Grasp Implications Of Orexigen 2:22 p.m. Dec. 19, 2014 - Seeking Alpha
Orexigen Therapeutics Gains On Diet Pill Nod From European Committee 1:09 p.m. Dec. 19, 2014 - benzinga.com
Orexigen's 'Goldilocks' Weight-Loss Pill is Just Right for European Regulators 8:25 a.m. Dec. 19, 2014 - TheStreet.com
Low-Cost Contrave Fuels Anti-Obesity Drugs Recovery From Thanksgiving 1:50 a.m. Dec. 16, 2014 - Seeking Alpha
Why Should Investors Expect Physicians To Treat Obesity With Pharmacotherapy? 10:30 a.m. Dec. 15, 2014 - Seeking Alpha
Zafgen starts clinical trial in severe obesity and type 2 diabetes 7:43 a.m. Dec. 15, 2014 - Seeking Alpha
Contrave Sales Continue To Impress 4:26 p.m. Dec. 12, 2014 - Seeking Alpha
Arena: Belviq Sales See Pleasant Rebound 4:05 p.m. Dec. 12, 2014 - Seeking Alpha
Arena Pharmaceuticals (ARNA) Weak On High Volume Today 10:01 a.m. Dec. 12, 2014 - TheStreet.com
Arena Pharmaceuticals Issued Composition of Matter Patent by United States Patent and Trademark Office for Ralinepag and Related Compounds 8:00 a.m. Nov. 25, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 8:00 a.m. Nov. 24, 2014 - PR Newswire - PRF
Technical Updates on Biotech Stocks - ImmunoGen, Lexicon Pharma, ZIOPHARM Oncology, Arena Pharma, and Regulus Therapeutics 8:40 a.m. Nov. 19, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Stifel 2014 Healthcare Conference 8:00 a.m. Nov. 13, 2014 - PR Newswire - PRF
Lorcaserin HCl Data to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases 8:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference 8:00 a.m. Nov. 5, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2014 Financial Results 6:45 a.m. Nov. 3, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Report Results of an Investigational Phase 2 Trial of Lorcaserin HCl as an Aid for Smoking Cessation 6:30 a.m. Nov. 3, 2014 - PR Newswire - PRF
Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting 7:37 a.m. Oct. 31, 2014 - PR Newswire - PRF
Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting 7:00 a.m. Oct. 31, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Report Results of an Investigational Pilot Study of Coadministration of Lorcaserin HCl and Phentermine HCl 5:20 p.m. Oct. 28, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Announces Third Quarter 2014 Conference Call and Webcast on Monday, November 3 7:00 a.m. Oct. 27, 2014 - PR Newswire - PRF
Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 8:30 a.m. Oct. 17, 2014 - PR Newswire - PRF
Global Anti-Obesity Drugs Market 4:07 p.m. Oct. 16, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Announce Publication of Pooled Phase 3 Clinical Trial Analysis of BELVIQ® (lorcaserin HCl) CIV in Postgraduate Medicine 10:36 a.m. Oct. 10, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 7:00 a.m. Sept. 22, 2014 - PR Newswire - PRF
Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 7:15 a.m. Sept. 19, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 7:40 a.m. Sept. 12, 2014 - PR Newswire - PRF
Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 7:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Post-Earnings Review and Highlights - Arena Pharma 8:30 a.m. Aug. 11, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼